NDAINJECTIONINJECTABLEPriority Review
Approved
Oct 2000
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
4
Data completeness
3/8 — Basic
Priority Review
NOVANTRONE (mitoxantrone hydrochloride) by Fresenius Kabi is clinical pharmacology: mechanism of action mitoxantrone, a dna-reactive agent that intercalates into deoxyribonucleic acid (dna) through hydrogen bonding, causes crosslinks and strand breaks. First approved in 2000.
Drug data last refreshed 18h ago · AI intelligence enriched 5d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
NOVANTRONE (mitoxantrone hydrochloride) is a DNA-reactive anthracenedione that intercalates into DNA, causes strand breaks, and inhibits topoisomerase II, exerting cytocidal effects on proliferating and nonproliferating cells. It is indicated for multiple sclerosis, acute myeloid leukemia, and advanced breast cancer. The drug demonstrates broad immunosuppressive activity by inhibiting B cell, T cell, and macrophage proliferation while impairing antigen presentation.
LOE Approaching
As a mature product approaching loss of exclusivity with moderate competitive pressure (30%), commercial teams should prepare for defensive strategies and transition planning.
Mechanism of Action
CLINICAL PHARMACOLOGY: Mechanism of Action Mitoxantrone, a DNA-reactive agent that intercalates into deoxyribonucleic acid (DNA) through hydrogen bonding, causes crosslinks and strand breaks. Mitoxantrone also interferes with ribonucleic acid (RNA) and is a potent inhibitor of topoisomerase II, an…
Worked on NOVANTRONE at Fresenius Kabi? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.